Shares of Kane Biotech Inc. (CVE:KNE – Get Free Report) shot up 14.3% during trading on Thursday . The stock traded as high as C$0.04 and last traded at C$0.04. 180,000 shares were traded during mid-day trading, an increase of 97% from the average session volume of 91,567 shares. The stock had previously closed at C$0.04.
Kane Biotech Stock Up 14.3%
The firm’s 50-day moving average price is C$0.04 and its 200 day moving average price is C$0.05. The company has a current ratio of 0.80, a quick ratio of 0.39 and a debt-to-equity ratio of -331.42. The company has a market capitalization of C$6.65 million, a price-to-earnings ratio of -0.44 and a beta of 0.23.
Kane Biotech Company Profile
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Read More
- Five stocks we like better than Kane Biotech
- Are Penny Stocks a Good Fit for Your Portfolio?
- AMD to $300 Looks Easy—Here’s Why $500 Could Be Next
- Business Services Stocks Investing
- $5B+ in Buybacks: What DraftKings, AppLovin, and Altria Are Telling You
- Best Stocks Under $5.00
- 4 High-Yield Real Estate Stocks to Buy as Investors Get Defensive
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
